Personal Genome Diagnostics (PGDx) is committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. Their expertise in advanced cancer genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. PGDx specializes in high-throughput next-generation sequencing, proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive approaches in cancer.